Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. (Q53491980)

14 May 2018

title

Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. (English)

1 reference

14 May 2018

1 reference

Susannah Yovino

1

1 reference

14 May 2018

Peter Darwin

2

1 reference

14 May 2018

Barry Daly

3

1 reference

14 May 2018

Michael Garofalo

4

1 reference

14 May 2018

Robert Moesinger

5

1 reference

14 May 2018

publication date

1 January 2007

1 reference

14 May 2018

Journal of Gastrointestinal Surgery

published in

1 reference

14 May 2018

volume

11

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

36-42

1 reference

14 May 2018

Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-007-0110-6

Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma

21 January 2018

1 reference

12 December 2020

Pain as a predictor of outcome in patients with operable pancreatic carcinoma

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies.

1 reference

12 December 2020

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

12 December 2020

Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms

1 reference

12 December 2020

Matched study of three methods for palliation of malignant pyloroduodenal obstruction

1 reference

12 December 2020

EUS-guided celiac plexus neurolysis and celiac plexus block

1 reference

12 December 2020

Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery

1 reference

12 December 2020

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Utility of tumor markers in determining resectability of pancreatic cancer.

1 reference

12 December 2020

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

12 December 2020

Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass

1 reference

12 December 2020

EUS in preoperative staging of pancreatic cancer

1 reference

12 December 2020

10.1007/S11605-007-0110-6

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018